scholarly journals Absorbed Radiation Dose

2020 ◽  
Author(s):  
Keyword(s):  
Radiation Dose ◽  
Absorbed Radiation Dose

The effect of dynamic wedge angle in breast cancer's absorbed radiation dose

2020 ◽  
Author(s):  
Nurul Fitriyah ◽  
Rahmatul Izza Nur Amalia ◽  
Bambang Haris Suhartono ◽  
Suryani Dyah Astuti
Keyword(s):  
Radiation Dose ◽  
Wedge Angle ◽  
Dynamic Wedge ◽  
Absorbed Radiation Dose

Selective fallopian tube catheterisation in female infertility: clinical results and absorbed radiation dose

1996 ◽  
Vol 6 (4) ◽  
Author(s):  
K. Nakamura ◽  
T. Ishiguchi ◽  
H. Maekoshi ◽  
Y. Ando ◽  
M. Tsuzaka ◽  
...  
Keyword(s):  
Radiation Dose ◽  
Fallopian Tube ◽  
Clinical Results ◽  
Female Infertility ◽  
Absorbed Radiation Dose

Biological Dosimetry of Absorbed Radiation Dose: Considerations of Low-Level Radiations

1990 ◽  
pp. 191-201 ◽  
Author(s):  
M. S. Sasaki ◽  
Y. Ejima ◽  
S. Saigusa
Keyword(s):  
Radiation Dose ◽  
Biological Dosimetry ◽  
Low Level ◽  
Absorbed Radiation Dose

ESTIMATION OF THE ABSORBED RADIATION DOSE OF MOUSE FETUS TAKEN FROM TRITIUM WATER-DRINKING PREGNANT MOUSE

1991 ◽  
pp. 323
Author(s):  
Y. FUJII ◽  
K. OHTA ◽  
S. NAKADA ◽  
H. OHYAMA ◽  
M. DALUSSALAM ◽  
...  
Keyword(s):  
Radiation Dose ◽  
Pregnant Mouse ◽  
Mouse Fetus ◽  
Water Drinking ◽  
Absorbed Radiation Dose

scholarly journals Percutaneous Coronary Intervention in Pregnancy: Modeling of the Fetal Absorbed Dose

2019 ◽  
Vol 2019 ◽  
pp. 1-5 ◽  
Author(s):  
Kfier Kuba ◽  
Diana Wolfe ◽  
Alan H. Schoenfeld ◽  
Anna E. Bortnick
Keyword(s):  
Myocardial Infarction ◽  
Percutaneous Coronary Intervention ◽  
Radiation Dose ◽  
Absorbed Dose ◽  
Coronary Intervention ◽  
Cardiac Procedures ◽  
Percutaneous Coronary ◽  
St Elevation ◽  
Absorbed Radiation Dose ◽  
In Pregnancy

There is a gap in the literature regarding fetal radiation exposure from interventional cardiac procedures. With an increasingly large and complex cohort of pregnant cardiac patients, it is necessary to evaluate the safety of invasive cardiac procedures and interventions in this population. Here we present a case of a patient with multiple medical comorbidities and non-ST elevation myocardial infarction (NSTEMI) at 15 weeks’ gestation, managed with percutaneous coronary intervention (PCI). We were able to minimize the maternal and estimated fetal absorbed radiation dose to <1 milliGray (mGy), significantly less than the threshold dose for fetal adverse effects at this gestational age.

Immunoscintigraphic localization of inflammatory lesions: Pharmacokinetics and estimated absorbed radiation dose in man

1988 ◽  
Vol 13 (11) ◽  
pp. 594-597 ◽  
Author(s):  
Peter H. Hasler ◽  
Klaus Seybold ◽  
Roger Y. Andres ◽  
Johannes T. Locher ◽  
P. August Schubiger
Keyword(s):  
Radiation Dose ◽  
Inflammatory Lesions ◽  
Absorbed Radiation Dose

A computer program to determine cumulated activity and absorbed radiation dose

1977 ◽  
Vol 4 (2) ◽  
pp. 152
Author(s):  
P.F. Butler ◽  
L.T. Fitzgerald ◽  
K.N. Vanek ◽  
V.A. Brookeman
Keyword(s):  
Radiation Dose ◽  
Computer Program ◽  
Absorbed Radiation Dose

High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: a phase I trial.

1997 ◽  
Vol 15 (4) ◽  
pp. 1518-1528 ◽  
Author(s):  
M Tempero ◽  
P Leichner ◽  
G Dalrymple ◽  
K Harrison ◽  
S Augustine ◽  
...  
Keyword(s):  
Stem Cells ◽  
Monoclonal Antibody ◽  
Radiation Dose ◽  
Phase I ◽  
Hematopoietic Stem Cells ◽  
Phase I Trial ◽  
Gastrointestinal Cancers ◽  
Hematopoietic Stem ◽  
Iodine 131 ◽  
Absorbed Radiation Dose

PURPOSE A phase I trial that evaluated for extrahematopoietic toxicity was conducted with iodine-131 (131I) labeled monoclonal antibody (MAb) CC49. Correlative studies included pharmacokinetic and biodistribution analyses, estimates of absorbed radiation dose, and measurement of human antimonoclonal antibodies (HAMA). PATIENTS AND METHODS After collection and cryopreservation of hematopoietic stem cells, 15 patients with gastrointestinal cancers were administered a tracer dose of 131I-MAb CC49. Within 5 to 6 days, 14 patients (two to three per activity level) underwent a single treatment with 131I-MAb CC49 (50, 100, 150, 200, 250, and 300 mCi/m2). Biodistribution was determined using planar and single photon emission computer tomographic (SPECT) imaging. Pharmacokinetic studies were performed by measuring radioactivity in serial blood samples. In some patients, biopsies of metastases and related normal tissues were obtained for radioactivity measurements. Radiation dosimetry estimates were calculated using available biodistribution, pharmacokinetic, and tissue biopsy data. Toxicity was evaluated using the National Cancer Institute (NCI) Common Toxicity Criteria. RESULTS No dose-limiting extrahematopoietic toxicity was identified. Twelve patients experienced grade IV myelosuppression and met criteria for infusion of hematopoietic stem cells. Radioimmunolocalization was excellent. The T1/2 for 131I-MAb CC49 after diagnostic and therapeutic administration was 39.7 +/- 10.4 and 46.1 +/- 10.6 hours, respectively. The percent injected dose per killigram of tumor ranged from 0.2 to 2.1. Absorbed radiation dose in metastatic tumor sites ranged from 630 to 3300 cGy. CONCLUSION Although extrahematopoietic dose-limiting toxicity was neither observed or predicted, suboptimal absorbed dose estimates suggested that further escalation of 131I-MAb CC49 would not be useful. Future studies should focus on the use of radionuclides with high energy beta emissions, such as yttrium 90, and on strategies to optimize access of antibody to target antigens.

Do we really care about absorbed radiation dose

1994 ◽  
Vol 21 (11) ◽  
Author(s):  
L.K. Harding ◽  
A. Bossuyt ◽  
S. Pellet ◽  
C. Reiners ◽  
J. Talbot
Keyword(s):  
Radiation Dose ◽  
Absorbed Radiation Dose
Sign in / Sign up

Export Citation Format

Share Document